Bridging the Gap Between Innovation and Capital
Newpath Partners
Focus on early-stage life science biotech companies developing therapeutics, and biopharma.
Program
Calling all early stage biotech; therapeutic, biopharma companies!
Founded in 2018, Newpath Partners is a venture capital firm headquartered in Boston, Massachusetts. The firm seeks to invest in early-stage companies working in the life sciences sectors.
Event
LaunchBio and Silicon Valley Bank, a division of First Citizens Bank, are pleased to announce their next Investor Connect virtual event with Newpath Partners.
Applications will be selected based on meeting the following criteria:
Geography:
Not restricted.
Company type:
Early-stage life science biotech companies developing therapeutics, and biopharma. (Particularly interested in supporting academic founders).
Areas of Interest:
- Gene Editing
- Neuroscience
- Metabolic pathways
- Small Molecule
- Drug Discovery
- Therapeutics
Stage:
Companies seeking pre-seed, seed.
Qualifying start-ups can apply here today.
Applications are accepted on a rolling basis. Learn more about LaunchBio’s Investor Connect series, in partnership with Silicon Valley Bank, a division of First Citizens Bank.